ArticleEJC skin cancer2025
Selecting first-line immunotherapy in advanced melanoma: Current evidence on efficacy across diverse patient populations.
Sophia Kreft et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it